SurgePays (SURG) Cost of Revenue (2010 - 2026)

SurgePays has disclosed Cost of Revenue across 17 years of filings, most recently posting $23.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 75.16% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $77.7 million (up 18.69% YoY), while the FY2025 annual figure was $67.6 million, down 10.18% from the prior year.
• Cost of Revenue rose to $23.7 million in Q1 2026, from $18.6 million in the prior quarter.
• Over the last five years, Cost of Revenue for SURG reached as high as $34.3 million in Q3 2022 and fell as low as $12.6 million in Q3 2024.
• The 5-year median for Cost of Revenue is $23.2 million (2024), against an average of $22.1 million.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 171.08% — and 2024, when it slumped 46.78%.
• A 5-year view of Cost of Revenue shows it stood at $29.5 million in 2022, then declined by 15.68% to $24.9 million in 2023, then declined by 16.27% to $20.8 million in 2024, then slipped by 10.78% to $18.6 million in 2025, then rose by 27.44% to $23.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $23.7 million, $18.6 million, and $21.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.